ES555143A0 - Procedimiento para preparar fenotoina en solucion - Google Patents
Procedimiento para preparar fenotoina en solucionInfo
- Publication number
- ES555143A0 ES555143A0 ES555143A ES555143A ES555143A0 ES 555143 A0 ES555143 A0 ES 555143A0 ES 555143 A ES555143 A ES 555143A ES 555143 A ES555143 A ES 555143A ES 555143 A0 ES555143 A0 ES 555143A0
- Authority
- ES
- Spain
- Prior art keywords
- phenotoin
- preparing
- procedure
- solution
- preparing phenotoin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/735,932 US4642316A (en) | 1985-05-20 | 1985-05-20 | Parenteral phenytoin preparations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES555143A0 true ES555143A0 (es) | 1987-07-16 |
| ES8707195A1 ES8707195A1 (es) | 1987-07-16 |
Family
ID=24957819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES555143A Expired ES8707195A1 (es) | 1985-05-20 | 1986-05-20 | Procedimiento para preparar fenotoina en solucion |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4642316A (es) |
| JP (1) | JPS61268618A (es) |
| AU (1) | AU595790B2 (es) |
| BE (1) | BE904476A (es) |
| CA (1) | CA1268119A (es) |
| CH (1) | CH668594A5 (es) |
| DE (1) | DE3610330A1 (es) |
| DK (1) | DK100786A (es) |
| ES (1) | ES8707195A1 (es) |
| FR (1) | FR2581871B1 (es) |
| GB (1) | GB2175203B (es) |
| IT (1) | IT1190282B (es) |
| LU (1) | LU86383A1 (es) |
| NL (1) | NL8600899A (es) |
| NZ (1) | NZ215783A (es) |
| PH (1) | PH22922A (es) |
| SE (1) | SE8600998L (es) |
| ZA (1) | ZA862094B (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3828156A1 (de) * | 1988-08-19 | 1990-02-22 | Astrapin Pharmazeutische Praep | Stabile waessrige loesung von fluorouracil |
| WO1999004798A1 (en) * | 1997-07-22 | 1999-02-04 | Warner-Lambert Company | Lyophilized fosphenytoin sodium for parenteral use |
| AU1917899A (en) | 1998-03-20 | 1999-10-18 | Warner-Lambert Company | Crystalline sodium phenytoin monohydrate |
| US6274168B1 (en) | 1999-02-23 | 2001-08-14 | Mylan Pharmaceuticals Inc. | Phenytoin sodium pharmaceutical compositions |
| WO2004058152A2 (en) * | 2002-12-16 | 2004-07-15 | Ranbaxy Pharmaceuticals Inc. | An extended release pharmaceutical composition of phenytoin sodium |
| EP2502649A1 (en) | 2005-02-03 | 2012-09-26 | TopoTarget UK Limited | Combination therapy using HDAC inhibitors and erlotinib for treating cancer |
| DE102005019393A1 (de) * | 2005-04-25 | 2006-10-26 | Basell Polyolefine Gmbh | Polyethylenformmassen für Spritzgussanwendungen |
| AU2012213940B2 (en) * | 2005-05-13 | 2015-03-26 | Topotarget Uk Limited | Pharmaceutical formulations of HDAC inhibitors |
| KR101329437B1 (ko) * | 2005-05-13 | 2013-11-14 | 토포타겟 유케이 리미티드 | Ｈｄａｃ 억제제의 약학 제형 |
| JP5377968B2 (ja) * | 2005-11-10 | 2013-12-25 | トポターゲット ユーケー リミテッド | 癌治療のために単独で用いるまたは化学療法薬と併用するヒストンデアセチラーゼ（ｈｄａｃ）阻害剤 |
| US8377979B2 (en) * | 2005-12-05 | 2013-02-19 | Taro Pharmaceuticals North America, Inc. | Pharmaceutical formulation containing phenytoin sodium and magnesium stearate |
| CN101868446A (zh) * | 2007-09-25 | 2010-10-20 | 托波塔吉特英国有限公司 | 某些异羟肟酸化合物的合成方法 |
| MX2010009642A (es) * | 2008-03-07 | 2010-09-22 | Topotarget As | Metodos de tratamiento utilizando infusion continua prolongada de belinostat. |
| GB0900555D0 (en) * | 2009-01-14 | 2009-02-11 | Topotarget As | New methods |
| MX364974B (es) | 2009-05-19 | 2019-05-16 | Neuroderm Ltd | Composiciones para la administracion continua de inhibidores de dopa descarboxilasa. |
| ES2776734T3 (es) | 2010-11-15 | 2020-07-31 | Neuroderm Ltd | Administración continua de L-dopa, inhibidores de dopa descarboxilasa, inhibidores de catecol-o-metil transferasa y composiciones para ello |
| WO2012082995A1 (en) | 2010-12-15 | 2012-06-21 | Nektar Therapeutics | Oligomer-containing hydantoin compounds |
| CN104349768B (zh) | 2012-06-05 | 2017-11-07 | 纽罗德姆有限公司 | 包含阿朴吗啡和有机酸的组合物及其用途 |
| MX2016011837A (es) | 2014-03-13 | 2017-04-27 | Neuroderm Ltd | Composiciones de inhibidores de la dopa decarboxilasa. |
| US10258585B2 (en) | 2014-03-13 | 2019-04-16 | Neuroderm, Ltd. | DOPA decarboxylase inhibitor compositions |
| US11331293B1 (en) | 2020-11-17 | 2022-05-17 | Neuroderm, Ltd. | Method for treatment of Parkinson's disease |
| US11844754B2 (en) | 2020-11-17 | 2023-12-19 | Neuroderm, Ltd. | Methods for treatment of Parkinson's disease |
| US11213502B1 (en) | 2020-11-17 | 2022-01-04 | Neuroderm, Ltd. | Method for treatment of parkinson's disease |
| WO2023205615A1 (en) * | 2022-04-18 | 2023-10-26 | ISHA Therapeutics LLC | Orally dissolving antimicrobial film compositions & methods of their use |
| US12109303B2 (en) | 2022-04-18 | 2024-10-08 | ISHA Therapeutics LLC | Orally dissolving antimicrobial film compositions and methods of their use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3749779A (en) * | 1970-08-27 | 1973-07-31 | American Home Prod | Stable solutions of sodium diphenylhydantoin |
| JPS5221575B2 (es) * | 1972-03-18 | 1977-06-11 | ||
| US4260769A (en) * | 1977-04-22 | 1981-04-07 | Interx Research Corporation | 5,5-Diphenylhydantoins |
| US4163058A (en) * | 1977-04-22 | 1979-07-31 | Interx Research Corporation | Derivatives of 5,5-diphenylhydantoin exhibiting enhanced solubility and the therapeutic use thereof |
-
1985
- 1985-05-20 US US06/735,932 patent/US4642316A/en not_active Expired - Fee Related
-
1986
- 1986-03-05 DK DK100786A patent/DK100786A/da not_active Application Discontinuation
- 1986-03-05 SE SE8600998A patent/SE8600998L/ not_active Application Discontinuation
- 1986-03-07 AU AU54412/86A patent/AU595790B2/en not_active Ceased
- 1986-03-13 CH CH1036/86A patent/CH668594A5/fr not_active IP Right Cessation
- 1986-03-20 ZA ZA862094A patent/ZA862094B/xx unknown
- 1986-03-20 FR FR868603981A patent/FR2581871B1/fr not_active Expired - Fee Related
- 1986-03-24 BE BE6/48212A patent/BE904476A/fr not_active IP Right Cessation
- 1986-03-25 GB GB08607383A patent/GB2175203B/en not_active Expired
- 1986-03-25 JP JP61065013A patent/JPS61268618A/ja active Pending
- 1986-03-26 DE DE19863610330 patent/DE3610330A1/de not_active Withdrawn
- 1986-04-01 LU LU86383A patent/LU86383A1/fr unknown
- 1986-04-09 NL NL8600899A patent/NL8600899A/nl not_active Application Discontinuation
- 1986-04-10 NZ NZ215783A patent/NZ215783A/xx unknown
- 1986-04-17 CA CA000506895A patent/CA1268119A/en not_active Expired - Fee Related
- 1986-04-24 IT IT47936/86A patent/IT1190282B/it active
- 1986-05-05 PH PH33734A patent/PH22922A/en unknown
- 1986-05-20 ES ES555143A patent/ES8707195A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2581871B1 (fr) | 1990-05-11 |
| NZ215783A (en) | 1989-01-27 |
| GB2175203B (en) | 1988-09-14 |
| DK100786A (da) | 1986-11-21 |
| FR2581871A1 (fr) | 1986-11-21 |
| SE8600998D0 (sv) | 1986-03-05 |
| NL8600899A (nl) | 1986-12-16 |
| LU86383A1 (fr) | 1986-09-02 |
| IT8647936A0 (it) | 1986-04-24 |
| IT1190282B (it) | 1988-02-16 |
| ZA862094B (en) | 1986-11-26 |
| JPS61268618A (ja) | 1986-11-28 |
| DE3610330A1 (de) | 1986-11-20 |
| GB2175203A (en) | 1986-11-26 |
| AU5441286A (en) | 1986-11-27 |
| US4642316A (en) | 1987-02-10 |
| BE904476A (fr) | 1986-09-24 |
| AU595790B2 (en) | 1990-04-12 |
| ES8707195A1 (es) | 1987-07-16 |
| PH22922A (en) | 1989-01-24 |
| CH668594A5 (fr) | 1989-01-13 |
| GB8607383D0 (en) | 1986-04-30 |
| DK100786D0 (da) | 1986-03-05 |
| SE8600998L (sv) | 1986-11-21 |
| CA1268119A (en) | 1990-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES555143A0 (es) | Procedimiento para preparar fenotoina en solucion | |
| ES557241A0 (es) | Procedimiento para preparar nuevos 2-aril-imidazoles | |
| ES557363A0 (es) | Procedimiento para preparar peptidos trifluormetilcetona-sustituidos | |
| ES544204A0 (es) | Procedimiento para preparar dialcoxipiridinas | |
| ES542976A0 (es) | Procedimiento para preparar pirrolo-bencimidazoles | |
| ES553989A0 (es) | Procedimiento para preparar 2,2,6,6-tetraalquil-4-piperidilaminas | |
| ES550730A0 (es) | Procedimiento para preparar poliesterpolioles | |
| ES551439A0 (es) | Procedimiento para preparar 4h-1-benzopiran-4-onas | |
| ES551807A0 (es) | Procedimiento para preparar piridinil acilhidrazonas | |
| ES550896A0 (es) | Procedimiento para preparar espiro-dioxolanos-ditiolanos y oxotiolanos | |
| MX159506A (es) | Procedimiento para preparar acidos quinolincarboxilicos | |
| ES557522A0 (es) | Procedimiento para preparar derivados de cinolina | |
| ES557692A0 (es) | Procedimiento para preparar derivados de imidazolilalquilguanidina | |
| ES555562A0 (es) | Procedimiento para preparar celalosporinas | |
| ES554112A0 (es) | Procedimiento para preparar compuestos de ciclohexil y cicloexenil-imidazol | |
| MX162986B (es) | Procedimiento para preparar n-formil-alfa-aspartil-fenilalanina | |
| MX160612A (es) | Procedimiento para preparar 3-carbonil-1-aminoalquil-1h-indoles | |
| ES548237A0 (es) | Procedimiento para preparar n6-bicicloadenosinas | |
| ES544622A0 (es) | Procedimiento para preparar l-fenilalamina | |
| ES551795A0 (es) | Procedimiento para preparar amino-alcoholes | |
| ES544074A0 (es) | Procedimiento para preparar naftoxacinas | |
| ES557630A0 (es) | Procedimiento para preparar dihidropiridinas | |
| ES552840A0 (es) | Procedimiento para preparar disulfuros heterociclicos | |
| MX162329A (es) | Procedimiento para preparar acilhidrazonas sulfeniladas | |
| MX159907A (es) | Procedimiento para preparar cloro-o-nitroanilinas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |
Effective date: 19960506 |